Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.
Núnez M, Camino N, Ramos B, Berdún MA, Barreiro P, Losada E, Santos I, Echevarría S, Ocampo A, Miralles C, Arazo P, Martín-Carbonero L, Romero M, García-Samaniego J, Soriano V.
Núnez M, et al. Among authors: soriano v.
Antivir Ther. 2005;10(5):657-62.
Antivir Ther. 2005.
PMID: 16152759
Clinical Trial.